Nuevocor names new chief medical officer
12 April 2024 -

Nuevocor, a pre-clinical stage biotechnology company, announced on Thursday that it has named Dr John Lee, MD, PhD, as its new chief Medical officer.

Dr Lee, a life science executive, has more than 15 years of clinical development and regulatory experience from early drug discovery to late-stage clinical development. He has most recently served as the chief medical officer of PhaseBio Pharmaceuticals. He has served as vice president, global head, Cardiovascular Center of Excellence at Quintiles and executive director, Discovery Medicine at Bristol-Myers Squibb, and has served in leadership roles in both biotech and pharmaceutical sectors.

Dr Yann Chong Tan, PhD, CEO and co-founder of Nuevocor, said, 'Dr Lee's appointment marks a significant milestone for Nuevocor. His extensive experience and proven track record in clinical development make him the ideal candidate to lead our clinical development team. His leadership will be instrumental in furthering our commitment to advancing science and translating it into therapies that will make a real difference in patients' lives.'